Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ron M. Philip currently holds 40,200 shares of Avalo Therapeutics, Inc. (AVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ron M. Philip has been a net neutral trader of AVTX stock. They have purchased $0 and sold $0 worth of shares.
Ron M. Philip's most recent insider trade was on Jun 23, 2026, when they sold 40,200 shares at $0.00 per share.
Ron M. Philip serves as Executive at Avalo Therapeutics, Inc. (AVTX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Ron M. Philip holds the position of Executive at Avalo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Ron M. Philip has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Ron M. Philip was on Jun 23, 2026, when they purchased $0 worth of AVTX shares. This transaction involved 40,200 shares at N/A per share.
Ron M. Philip currently owns 40,200 shares of Avalo Therapeutics, Inc. (AVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ron M. Philip's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ron M. Philip has 1 Form 4 filings on record as an insider at Avalo Therapeutics, Inc..
Set alerts for Ron M. Philip and 40,000+ other insiders.